The genetic confirmation of ATP7B mutations, coupled with the positive response to chelation therapy, strongly supports the diagnosis of Wilson Disease as the cause of the patient’s neurological and psychiatric symptoms. The gene discussed is ATP7B; the disease is Wilson disease.